Midday Losers From Tuesday, September 2
September 02, 2014 at 14:15 PM EDT
Exelixis (NASDAQ: EXEL) -54% - Shares dropped following disappointing phase 3 trials of Cabozantinib. CONN’S (NASDAQ: CONN) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.